Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma
使用新型 CDK9/p-TEFb 抑制剂(联合或不联合 5-氟尿嘧啶)靶向治疗食管腺癌中的 CDK9 和 MCL-1
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.3
doi:10.1177/1758835919864850
Zhimin Tong, Alicia Mejia, Omkara Veeranki, Anuj Verma, Arlene M Correa, Rashmi Dokey, Viren Patel, Luisa Maren Solis, Barbara Mino, Riham Kathkuda, Jaime Rodriguez-Canales, Steven H Lin, Sunil Krishnan, Scott Kopetz, Mariela Blum, Jaffer A Ajani, Wayne L Hofstetter, Dipen M Maru